Nicorette nicotine replacement therapy

Nicorette is a pioneer in nicotine replacement therapy (NRT), having been developed in the late 1960s in Sweden by Ove Fernö. The brand's origin is rooted in medical research conducted for the Swedish Navy to help submariners who were unable to smoke while underwater. Since its commercial debut in the 1970s, it has become the global gold standard for smokers seeking to quit.

Today, the brand's ownership structure is split geographically due to historical corporate spin-offs and acquisitions. In the United States, the brand is owned and distributed by Haleon, a consumer healthcare company that spun off from GlaxoSmithKline (GSK). Globally (outside the US), the brand is primarily owned by Kenvue, the consumer health division that was formerly part of Johnson & Johnson. Manufacturing remains concentrated in specialized pharmaceutical facilities in Helsingborg, Sweden, and various sites in Switzerland to ensure high clinical standards.